DePuy Synthes Rolls Out Three New Products

During a recent meeting with members of the investment community, senior leaders from the Medical Devices and Diagnostics (MD&D) segment of New Brunswick, N.J.-based healthcare conglomorate Johnson & Johnson JNJ) outlined the company’s plans to improve patient outcomes and expand its market reach through innovative products, new business models and a focus on emerging markets.


Johnson & Johnson’s medical device division, which includes the DePuy Synthes orthopedic unit, is the world’s largest medical devices and diagnostics business, with $28.5 billion in total sales for 2013.

To expand its global leadership position, the MD&D segment invested nearly $1.8 billion in research and development in 2013, officials said.

The company device and diagnostic businesses plan more than 30 major product filings by the end of 2016.

“Our businesses are uniquely positioned to continue helping patients while also leading the industry by capitalizing on our breadth, depth and scale,” said Dominic J. Caruso, vice president of finance and chief financial officer for Johnson & Johnson. “We are developing innovative products and working with health care systems on customer-focused solutions to ultimately improve outcomes for patients.”


The medical device segment of emerging markets is growing three-to-four times faster than the developed markets, according to JNJ officials. For 2013, the company posted almost $6 billion in sales in the MD&D segment coming from these markets—more than 20 percent of its worldwide 2013 sales 


During the meeting, DePuy Synthes rolled out three new products:
• The Global Unite anatomic shoulder system, which is part of a larger platform designed, according to DePuy Synthes officials, to allow surgeons to repair or replace shoulders in a “simpler and more efficient manner” while optimizing the patient’s range of motion;
• The Corail revision hip system is the first tapered wedge revision system in the United States and is engineered to reduce the operating room footprint while delivering patient benefits through its bone-preserving design; and
• The Trumatch resection guide for the recently launched Attune rotating platform knee. Trumatch personalized solutions provides patient-specific instruments developed from a CT scan to reduce surgical steps and customize the procedure to each patient.